Not Yet Recruiting
A Single Ascending Dose Study of DT-216P2 in Normal Healthy Participants
NCT06772870
- Conditions
- Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +11 more
- Locations
-
- Nucleus Network, Level 5, 89 Commercial Road Melbourne, Victoria, Australia